Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Renal Cell | 13 | 2023 | 2952 | 1.850 |
Why?
|
Kidney Neoplasms | 11 | 2023 | 4015 | 1.560 |
Why?
|
Wilms Tumor | 1 | 2022 | 340 | 0.740 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2020 | 604 | 0.570 |
Why?
|
Carcinoma, Papillary | 1 | 2020 | 792 | 0.530 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2022 | 319 | 0.370 |
Why?
|
Papillomavirus Infections | 4 | 2020 | 1512 | 0.310 |
Why?
|
Butyrate Response Factor 1 | 1 | 2022 | 10 | 0.230 |
Why?
|
Indans | 1 | 2022 | 99 | 0.210 |
Why?
|
Paris | 1 | 2020 | 44 | 0.200 |
Why?
|
Head and Neck Neoplasms | 3 | 2019 | 2718 | 0.190 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2022 | 262 | 0.190 |
Why?
|
Sulfones | 1 | 2022 | 456 | 0.180 |
Why?
|
Anilides | 1 | 2022 | 412 | 0.170 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2022 | 353 | 0.170 |
Why?
|
In Situ Hybridization | 2 | 2019 | 1987 | 0.160 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2020 | 225 | 0.160 |
Why?
|
Mutation | 2 | 2021 | 29270 | 0.150 |
Why?
|
Translocation, Genetic | 1 | 2022 | 1412 | 0.150 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2018 | 457 | 0.140 |
Why?
|
Immunotherapy | 3 | 2021 | 4089 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 1137 | 0.140 |
Why?
|
Gene Dosage | 1 | 2020 | 1269 | 0.140 |
Why?
|
Pathology, Clinical | 1 | 2019 | 368 | 0.130 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2645 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1593 | 0.120 |
Why?
|
Papillomavirus Vaccines | 1 | 2020 | 487 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1356 | 0.120 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 3050 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2018 | 3991 | 0.110 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11665 | 0.110 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 1891 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2018 | 1139 | 0.110 |
Why?
|
Sarcoma | 1 | 2023 | 1879 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1568 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2943 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4286 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4264 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2022 | 8561 | 0.100 |
Why?
|
Pyridines | 1 | 2022 | 2843 | 0.090 |
Why?
|
RNA, Viral | 1 | 2018 | 2869 | 0.090 |
Why?
|
Computational Biology | 1 | 2021 | 3569 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2022 | 12530 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 1973 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3670 | 0.080 |
Why?
|
Humans | 20 | 2023 | 715636 | 0.080 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11138 | 0.070 |
Why?
|
MicroRNAs | 1 | 2021 | 3620 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 727 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 4907 | 0.060 |
Why?
|
Phenotype | 1 | 2020 | 16308 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17399 | 0.050 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2022 | 286 | 0.050 |
Why?
|
Fumarate Hydratase | 1 | 2020 | 47 | 0.050 |
Why?
|
Female | 8 | 2022 | 377052 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2022 | 297 | 0.050 |
Why?
|
Male | 7 | 2022 | 350156 | 0.050 |
Why?
|
Gene Fusion | 1 | 2022 | 370 | 0.040 |
Why?
|
Angiomyolipoma | 1 | 2020 | 186 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 568 | 0.040 |
Why?
|
Transcription Factors | 3 | 2023 | 11955 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58288 | 0.040 |
Why?
|
France | 1 | 2019 | 494 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 51355 | 0.040 |
Why?
|
Epigenomics | 1 | 2023 | 806 | 0.040 |
Why?
|
Oncogenes | 1 | 2023 | 1246 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 712 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2022 | 72439 | 0.040 |
Why?
|
Salvage Therapy | 1 | 2023 | 1307 | 0.040 |
Why?
|
Aged | 4 | 2021 | 162383 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1597 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1044 | 0.030 |
Why?
|
Education, Distance | 1 | 2019 | 253 | 0.030 |
Why?
|
Prognosis | 3 | 2021 | 28987 | 0.030 |
Why?
|
Adolescent | 1 | 2022 | 85064 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1885 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3523 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1723 | 0.030 |
Why?
|
Middle Aged | 3 | 2021 | 214618 | 0.030 |
Why?
|
DNA, Viral | 1 | 2018 | 2291 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2022 | 3064 | 0.030 |
Why?
|
Adult | 2 | 2020 | 212228 | 0.020 |
Why?
|
Vaccination | 1 | 2020 | 2936 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3347 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6726 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2208 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5747 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16729 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5406 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8997 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2021 | 9741 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11233 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40042 | 0.010 |
Why?
|
Animals | 1 | 2018 | 169277 | 0.000 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_